Skip to main content
FinSpry Logo
FinSpry
CGON logo
CGON
(NASDAQ)
CG Oncology, Inc.
$67.48-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

CG Oncology (CGON) Stock Price & Financial Analysis

CG Oncology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$65.97 - $68.40
52-Week High$69.35
52-Week Low$14.80
Open$65.99
Volume1.28M
Average Volume (3M)1.28M
Market Cap5.22B
Shares Outstanding77.30M
Price to Sales (P/S)1277.99
Price to Book (P/B)6.86
EV/EBITDA-28.24
Revenue (TTM)4.04M
Net Income (TTM)-161.00M
Free Cash Flow (TTM)-132.48M
EPS (TTM)$-2.08
Profit Margin-3985.02%
Operating Margin-4722.13%
Return on Equity (ROE)-21.39%
Debt to Equity0.01
50-Day MA$58.76
200-Day MA$41.46
52-Week Change202.90%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About CG Oncology

What is the current stock price for CGON?

As of the latest trading session, CGON stock trades at $67.48. The 52-week range is $14.80–$69.35, with a day range of $65.97–$68.40.

What is the P/E ratio for CGON?

The P/E ratio (Price-to-Earnings) for CGON is shown in the Key Statistics section. This valuation metric helps compare CG Oncology, Inc. to industry peers.

Does CGON pay dividends?

CG Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CGON?

Based on 17 analysts, the consensus for CGON is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CGON?

CG Oncology's market capitalization is $5.22B, classifying it as a mid-cap company. CG Oncology operates in the Healthcare sector within the Biotechnology industry.